296.10DKK-0.02%Mkt Cap: 190.75B $P/E: 11.28Today
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare D…
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap190.75B $
Enterprise Value204.99B $
Revenue (TTM)47.98B $
Gross Profit36.45B $
Net Income (TTM)14.92B $
Revenue/Share10.81 USD
Last Price296.10 DKK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees66.7K
CountryDK
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS6701002056
Valuation
P/E (Trailing)11.28
P/E (Forward)13.52
PEG3.11
EV/EBITDA8.10
EV/Revenue4.27
P/S3.98
P/B5.93
EPS (TTM)26.26
EPS (Forward)21.91
52W Range
224.2539% of range409.95
52W High409.95 DKK
52W Low224.25 DKK
Profitability
Gross Margin80.98%
Oper. Margin42.54%
EBITDA Margin52.72%
Profit Margin33.14%
ROE52.79%
ROA18.87%
Growth
Revenue Growth2.10%
Earnings Growth-20.60%
Cash Flow & Leverage
Operating CF17.35B $
CapEx (TTM)13.13B $
FCF Margin11.44%
FCF Yield2.88%
Net Debt13.86B $
Net Debt/EBITDA0.55
Balance Sheet
Debt/Equity0.67
Current Ratio0.87
Quick Ratio0.64
Book Value/Sh49.97 DKK
Cash/Share10.16 DKK
Dividends
Fwd Div Rate11.70 DKK
Trail. Div Rate11.70 DKK
Div. Yield4.00%
5Y Avg Yield1.88%
Payout Ratio44.57%
Ex-Div DateAug 14, 2026
Pay Date—
Splits
Last Split2:1
Split DateSep 13, 2023
Analyst Consensus
Rating2.7 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)313.70 DKK
Upside (mean)+5.9%
Target Range203.00 DKK – 457.00 DKK
DKK203.00+5.9% to meanDKK457.00
# Analysts24
Ownership
Shares Out.3.35B
Float3.17B
Insiders5.28%
Institutions33.39%
Technical
SMA 50310.35 (-4.6%)
SMA 200299.38 (-1.1%)
Beta0.35
S&P 52W Chg19.97%
Avg Vol (30d)3.86M
Avg Vol (10d)5.12M
Technical Indicators
RSI (14)41.9
MACD-5.3661
MACD Signal-3.7198
MACD Hist.-1.6463
BB Upper337.90 DKK
BB Middle308.81 DKK
BB Lower279.72 DKK
BB Width18.84%
ATR (14)10.07 DKK
Vol Ratio (20d)0.67x